Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Post-traumatic Stress Disorder01:27

Post-traumatic Stress Disorder

32
Post-traumatic stress disorder (PTSD) is a psychiatric condition that arises following exposure to traumatic events such as natural disasters, forced displacement, or severe accidents. It significantly impairs individuals' ability to cope with daily activities and disrupts their emotional and psychological equilibrium.
Symptoms and Behavioral Manifestations
A spectrum of distressing symptoms characterizes PTSD. Recurrent flashbacks, where individuals involuntarily relive traumatic events,...
32
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

36
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
36
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

226
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
226
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

181
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
181

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reducing Intrusive Trauma Memories Using a Brief Mental Imagery Competing Task Intervention: Case Series of Trauma-Exposed Women in Iceland.

JMIR formative research·2026
Same author

[Marked increase in alcohol-related admissions to Landspitali].

Laeknabladid·2026
Same author

Genome-wide association study of borderline personality disorder identifies 11 loci and highlights shared risk with mental and somatic disorders.

medRxiv : the preprint server for health sciences·2025
Same author

Risk of hospitalisation for first-onset psychosis or mania within a year of ADHD medication initiation in adults with ADHD.

BMJ mental health·2025
Same author

Rare loss-of-function variants in HECTD2 and AKAP11 confer risk of bipolar disorder.

Nature genetics·2025
Same author

[Balancing mood, the will to live and risk of side-effects on lithium therapy].

Laeknabladid·2025

Related Experiment Video

Updated: Jun 27, 2025

Simultaneous Application of Transcranial Direct Current Stimulation during Virtual Reality Exposure
08:20

Simultaneous Application of Transcranial Direct Current Stimulation during Virtual Reality Exposure

Published on: January 18, 2021

4.0K

[MDMA-assisted therapy for PTSD].

Helga Thorarinsdottir1, Berglind Gudmundsdottir2, Engilbert Sigurdsson2

  • 1Mental Health Services Landspitali University Hospital, Iceland.

Laeknabladid
|May 7, 2024
PubMed
Summary
This summary is machine-generated.

MDMA-assisted therapy shows promise for treating post-traumatic stress disorder (PTSD). This novel approach combines medication with psychotherapy to reduce distress and improve outcomes for PTSD patients.

Keywords:
MDMAPTSDempathogenentactogenpsychedelicspsychotherapy

More Related Videos

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

13.9K
Biomarkers in an Animal Model for Revealing Neural, Hematologic, and Behavioral Correlates of PTSD
08:29

Biomarkers in an Animal Model for Revealing Neural, Hematologic, and Behavioral Correlates of PTSD

Published on: October 10, 2012

16.0K

Related Experiment Videos

Last Updated: Jun 27, 2025

Simultaneous Application of Transcranial Direct Current Stimulation during Virtual Reality Exposure
08:20

Simultaneous Application of Transcranial Direct Current Stimulation during Virtual Reality Exposure

Published on: January 18, 2021

4.0K
MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

13.9K
Biomarkers in an Animal Model for Revealing Neural, Hematologic, and Behavioral Correlates of PTSD
08:29

Biomarkers in an Animal Model for Revealing Neural, Hematologic, and Behavioral Correlates of PTSD

Published on: October 10, 2012

16.0K

Area of Science:

  • Psychiatry
  • Psychopharmacology
  • Trauma Studies

Background:

  • Post-traumatic stress disorder (PTSD) represents a significant unmet medical need.
  • Current PTSD treatments have limitations in efficacy and patient adherence.
  • MDMA (3,4-methylenedioxymethamphetamine) is being investigated as a novel therapeutic agent.

Purpose of the Study:

  • To review current knowledge on MDMA and its application in MDMA-assisted psychotherapy for PTSD.
  • To synthesize findings from recent studies on MDMA's efficacy and safety in PTSD treatment.
  • To highlight the need for further research and regulatory evaluation.

Main Methods:

  • Comprehensive literature searches were conducted across PubMed, Web of Science, and Google Scholar.
  • References from identified articles were reviewed to gather relevant data.
  • The review synthesized information on the protocol and outcomes of MDMA-assisted therapy for PTSD.

Main Results:

  • MDMA-assisted psychotherapy involves preparatory, dosing, and integrative sessions with trained therapists.
  • This therapeutic model aims to reduce psychological distress during trauma processing, facilitating treatment.
  • Recent studies suggest MDMA-assisted psychotherapy effectively reduces PTSD symptoms and is well-tolerated.

Conclusions:

  • MDMA-assisted psychotherapy demonstrates potential as a novel and effective treatment for PTSD.
  • Further rigorous studies are essential for regulatory approval of MDMA-assisted therapy.
  • Comparative studies with existing PTSD treatments are needed to establish its place in clinical practice.